These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17706021)

  • 1. The spectrum and types of adverse side effects to biological immune modulators: a proposal for new classification.
    Zemková M; Jebavý L; Kotlárová J; Vlcek J; Meyboom RH
    Folia Biol (Praha); 2007; 53(4):146-55. PubMed ID: 17706021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse side-effects to biological agents.
    Pichler WJ
    Allergy; 2006 Aug; 61(8):912-20. PubMed ID: 16867042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complex clinical picture of side effects to biologicals.
    Hausmann OV; Seitz M; Villiger PM; Pichler WJ
    Med Clin North Am; 2010 Jul; 94(4):791-804, xi-ii. PubMed ID: 20609863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complexity of adverse side-effects to biological agents.
    Aubin F; Carbonnel F; Wendling D
    J Crohns Colitis; 2013 May; 7(4):257-62. PubMed ID: 22819590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathomechanism of Adverse Reactions to Biological Treatment of Inflammatory Skin Conditions.
    Li L; Naisbitt DJ; Sun Y; Zhang F
    Clin Exp Allergy; 2024 Oct; ():. PubMed ID: 39428352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse reactions to biologic agents: focus on autoimmune disease therapies.
    Lee SJ; Kavanaugh A
    J Allergy Clin Immunol; 2005 Oct; 116(4):900-5. PubMed ID: 16210067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypersensitivity reactions to biological drugs.
    Corominas M; Gastaminza G; Lobera T
    J Investig Allergol Clin Immunol; 2014; 24(4):212-25; quiz 1p following 225. PubMed ID: 25219103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side effect profile similarities shared between antidepressants and immune-modulators reveal potential novel targets for treating major depressive disorders.
    Sun Y; Narayan VA; Wittenberg GM
    BMC Pharmacol Toxicol; 2016 Oct; 17(1):47. PubMed ID: 27765060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting cytokines to tumors to induce active antitumor immune responses by recombinant fusion proteins.
    Xiang J
    Hum Antibodies; 1999; 9(1):23-36. PubMed ID: 10331183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and potential clinical applications of autoantibodies against cytokines.
    de Lemos Rieper C; Galle P; Hansen MB
    Cytokine Growth Factor Rev; 2009 Feb; 20(1):61-75. PubMed ID: 19213592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview on safety of monoclonal antibodies.
    Matucci A; Nencini F; Pratesi S; Maggi E; Vultaggio A
    Curr Opin Allergy Clin Immunol; 2016 Dec; 16(6):576-581. PubMed ID: 27749360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The revised Gell and Coombs classification: a new reading of old truths in the context of immunodeficiencies theory].
    Mal'tsev DV; Kazmirchuk VE; Tsarik VV
    Lik Sprava; 2012; (1-2):28-44. PubMed ID: 23035598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-Cytokine Fusions: Versatile Products for the Modulation of Anticancer Immunity.
    Neri D
    Cancer Immunol Res; 2019 Mar; 7(3):348-354. PubMed ID: 30824549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biological response modifiers in the treatment of immunoinflammatory diseases].
    Skov L; Bendtzen K
    Ugeskr Laeger; 2008 Jun; 170(24):2120-6. PubMed ID: 18565292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-cytokine fusion proteins.
    Kontermann RE
    Arch Biochem Biophys; 2012 Oct; 526(2):194-205. PubMed ID: 22445675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing patients with side effects and adverse events to immunoglobulin therapy.
    Azizi G; Abolhassani H; Asgardoon MH; Shaghaghi S; Negahdari B; Mohammadi J; Rezaei N; Aghamohammadi A
    Expert Rev Clin Pharmacol; 2016; 9(1):91-102. PubMed ID: 26496172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in basic and clinical immunology in 2007.
    Chinen J; Shearer WT
    J Allergy Clin Immunol; 2008 Jul; 122(1):36-41. PubMed ID: 18514804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulators for allergic respiratory disorders.
    Casale TB; Stokes JR
    J Allergy Clin Immunol; 2008 Feb; 121(2):288-96; quiz 297-8. PubMed ID: 18269921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential adverse events with biologic response modifiers.
    Kong JS; Teuber SS; Gershwin ME
    Autoimmun Rev; 2006 Aug; 5(7):471-85. PubMed ID: 16920574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Wide Spectrum of Autoimmune Manifestations and Other Symptoms Suggesting Immune Dysregulation in Patients With Cartilage-Hair Hypoplasia.
    Vakkilainen S; Mäkitie R; Klemetti P; Valta H; Taskinen M; Husebye ES; Mäkitie O
    Front Immunol; 2018; 9():2468. PubMed ID: 30410491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.